A Study to Evaluate the Safety and Efficacy of AVTX-002 for the Treatment of Poorly Controlled Non-Eosinophilic Asthma.
Status:
Recruiting
Trial end date:
2022-09-19
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the efficacy of AVTX-002 compared with
placebo in patients with poorly controlled non-eosinophilic asthma (NEA).